| |
| |
|
| Insider
Information: |
Ciechanover Isaac E. |
| Relationship: |
Chief Executive Office... |
| City: |
Brisbane |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
332,243 |
|
|
Indirect Shares
|
290,687 |
|
|
| Direct
Value |
$230,344 |
|
|
|
Indirect Value
|
$201,533 |
|
|
| Total
Shares |
622,930 |
|
|
| Total
Value |
$431,877 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Atara Biotherapeutics, Inc. |
ATRA |
Chief Executive Office... |
2019-05-30 |
332,243 |
2019-05-30 |
290,687 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
209 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 9
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2017-02-16 |
4 |
AS |
$15.57 |
$37,368 |
I/I |
(2,400) |
348,978 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-10-13 |
4 |
AS |
$15.91 |
$38,184 |
I/I |
(2,400) |
404,178 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2017-07-25 |
4 |
AS |
$15.97 |
$43,283 |
I/I |
(2,700) |
450,578 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-10-14 |
4 |
AS |
$16.01 |
$38,424 |
I/I |
(2,400) |
401,778 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2017-07-24 |
4 |
AS |
$16.89 |
$47,421 |
I/I |
(2,800) |
453,278 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2017-04-11 |
4 |
AS |
$16.99 |
$71,358 |
I/I |
(4,200) |
474,978 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2017-04-25 |
4 |
AS |
$17.07 |
$62,397 |
I/I |
(3,600) |
471,378 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2017-04-10 |
4 |
AS |
$17.08 |
$51,240 |
I/I |
(3,000) |
479,178 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-12-07 |
4 |
AS |
$17.30 |
$62,280 |
I/I |
(3,600) |
377,778 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-05-26 |
4 |
AS |
$17.35 |
$62,460 |
I/I |
(3,600) |
356,311 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2017-04-26 |
4 |
AS |
$17.78 |
$64,008 |
I/I |
(3,600) |
467,778 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-05-25 |
4 |
AS |
$18.03 |
$64,908 |
I/I |
(3,600) |
359,911 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-11-22 |
4 |
AS |
$18.21 |
$152,964 |
I/I |
(8,400) |
388,578 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2017-12-29 |
4 |
AS |
$18.24 |
$372,628 |
I/I |
(20,000) |
388,778 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-11-23 |
4 |
AS |
$18.40 |
$67,142 |
I/I |
(3,600) |
384,978 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2017-03-17 |
4 |
AS |
$18.50 |
$396,576 |
I/I |
(20,000) |
498,178 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2017-03-16 |
4 |
AS |
$18.54 |
$200,232 |
I/I |
(10,800) |
518,178 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-12-06 |
4 |
AS |
$18.55 |
$66,780 |
I/I |
(3,600) |
381,378 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2017-03-28 |
4 |
AS |
$18.99 |
$68,728 |
I/I |
(3,600) |
482,178 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-09-16 |
4 |
AS |
$19.32 |
$69,552 |
I/I |
(3,600) |
418,578 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-09-15 |
4 |
AS |
$19.39 |
$69,804 |
I/I |
(3,600) |
422,178 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-01-10 |
4 |
AS |
$19.64 |
$171,938 |
I/I |
(8,600) |
380,178 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-03-31 |
4 |
AS |
$20.01 |
$6,003 |
I/I |
(300) |
378,911 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-04-01 |
4 |
AS |
$20.04 |
$17,836 |
I/I |
(890) |
378,021 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-01-14 |
4 |
AS |
$20.07 |
$24,084 |
I/I |
(1,200) |
379,211 |
0 |
- |
|
209 Records found
|
|
Page 3 of 9 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
